117 related articles for article (PubMed ID: 7564751)
1. Bronchodilation subsensitivity to salbutamol after salmeterol.
Barnes N
Lancet; 1995 Oct; 346(8980):968; author reply 968-9. PubMed ID: 7564751
[No Abstract] [Full Text] [Related]
2. Bronchodilation subsensitivity to salbutamol after salmeterol.
Weinberger M
Lancet; 1995 Oct; 346(8980):968-9. PubMed ID: 7564753
[No Abstract] [Full Text] [Related]
3. Bronchodilation subsensitivity to salbutamol after salmeterol.
Ng HW
Lancet; 1995 Oct; 346(8980):968; author reply 968-9. PubMed ID: 7564752
[No Abstract] [Full Text] [Related]
4. Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol.
Lipworth BJ; Jackson CM
Chest; 2002 Apr; 121(4):1382. PubMed ID: 11948092
[No Abstract] [Full Text] [Related]
5. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
Britton MG; Earnshaw JS; Palmer JB
Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
[TBL] [Abstract][Full Text] [Related]
6. The first 20 minutes after a single dose of inhaled salmeterol in asthmatic children.
Barbato A; Cracco A; Tormena F; Novello A
Allergy; 1995 Jun; 50(6):506-10. PubMed ID: 7573844
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
8. Systemic effects of salbutamol and salmeterol in patients with asthma.
Bennett JA; Smyth ET; Pavord ID; Wilding PJ; Tattersfield AE
Thorax; 1994 Aug; 49(8):771-4. PubMed ID: 8091321
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma.
Adkins JC; McTavish D
Drugs; 1997 Aug; 54(2):331-54. PubMed ID: 9257086
[TBL] [Abstract][Full Text] [Related]
10. Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol.
Maconochie JG; Denyer LH; Hassani H
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):329-34. PubMed ID: 7952793
[TBL] [Abstract][Full Text] [Related]
11. Acute bronchodilatory effect of salmeterol on methacholine-induced bronchoconstriction in childhood asthma.
Baki A; Karagüzel G
Acta Paediatr Jpn; 1998 Apr; 40(2):135-7. PubMed ID: 9581303
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler.
Wilkinson JR; Roberts JA; Bradding P; Holgate ST; Howarth PH
BMJ; 1992 Oct; 305(6859):931-2. PubMed ID: 1360855
[No Abstract] [Full Text] [Related]
13. Duration and magnitude of action of 50 and 100 micrograms of inhaled salmeterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in subjects with asthma.
Cartier A; Ghezzo H; L'Archevêque J; Trudeau C; Malo JL
J Allergy Clin Immunol; 1993 Sep; 92(3):488-92. PubMed ID: 8360399
[No Abstract] [Full Text] [Related]
14. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
Weinstein SF; Pearlman DS; Bronsky EA; Byrne A; Arledge T; Liddle R; Stahl E
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):51-8. PubMed ID: 9690573
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA
Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669
[TBL] [Abstract][Full Text] [Related]
19. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
[TBL] [Abstract][Full Text] [Related]
20. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
